SLC2A6 and central nervous system cancer: The combination of Simvastatin and metformin influences the expression of GLUT1 and GLUT6 in glioma cells, inhibits malignant proliferation, and promotes apoptosis, providing novel ideas for the combination treatment of gliomas [68].